126 related articles for article (PubMed ID: 22206449)
1. Surgery of skeletal metastases in 306 patients with prostate cancer.
Weiss RJ; Forsberg JA; Wedin R
Acta Orthop; 2012 Feb; 83(1):74-9. PubMed ID: 22206449
[TBL] [Abstract][Full Text] [Related]
2. Complications and survival after surgical treatment of 214 metastatic lesions of the humerus.
Wedin R; Hansen BH; Laitinen M; Trovik C; Zaikova O; Bergh P; Kalén A; Schwarz-Lausten G; Vult von Steyern F; Walloe A; Keller J; Weiss RJ
J Shoulder Elbow Surg; 2012 Aug; 21(8):1049-55. PubMed ID: 21982491
[TBL] [Abstract][Full Text] [Related]
3. Surgery for skeletal metastases in lung cancer.
Weiss RJ; Wedin R
Acta Orthop; 2011 Feb; 82(1):96-101. PubMed ID: 21281260
[TBL] [Abstract][Full Text] [Related]
4. Surgical treatment for pathologic fracture.
Wedin R
Acta Orthop Scand Suppl; 2001 Jun; 72(302):2p., 1-29. PubMed ID: 11582636
[TBL] [Abstract][Full Text] [Related]
5. Skeletal metastases in 301 breast cancer patients: patient survival and complications after surgery.
Weiss RJ; Tullberg E; Forsberg JA; Bauer HC; Wedin R
Breast; 2014 Jun; 23(3):286-90. PubMed ID: 24684891
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors influencing overall survival in de novo oligometastatic prostate cancer patients.
Rii J; Sakamoto S; Yamada Y; Takeshita N; Yamamoto S; Sazuka T; Imamura Y; Nakamura K; Komiya A; Komaru A; Fukasawa S; Nakatsu H; Akakura K; Ichikawa T
Prostate; 2020 Aug; 80(11):850-858. PubMed ID: 32501559
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and prognostic factors for patients with bone metastases from prostate cancer.
He J; Zeng ZC; Yang P; Chen B; Jiang W; Du SS
Asian J Androl; 2012 May; 14(3):505-8. PubMed ID: 22504872
[TBL] [Abstract][Full Text] [Related]
8. Massive endoprosthetic replacement for bone metastases resulting from renal cell carcinoma: factors influencing patient survival.
Hwang N; Nandra R; Grimer RJ; Carter SR; Tillman RM; Abudu A; Jeys LM
Eur J Surg Oncol; 2014 Apr; 40(4):429-34. PubMed ID: 24063967
[TBL] [Abstract][Full Text] [Related]
9. Skeletal related events, bone metastasis and survival of prostate cancer: a population based cohort study in Denmark (1999 to 2007).
Nørgaard M; Jensen AØ; Jacobsen JB; Cetin K; Fryzek JP; Sørensen HT
J Urol; 2010 Jul; 184(1):162-7. PubMed ID: 20483155
[TBL] [Abstract][Full Text] [Related]
10. Impact of the Site of Metastases on Survival in Patients with Metastatic Prostate Cancer.
Gandaglia G; Karakiewicz PI; Briganti A; Passoni NM; Schiffmann J; Trudeau V; Graefen M; Montorsi F; Sun M
Eur Urol; 2015 Aug; 68(2):325-34. PubMed ID: 25108577
[TBL] [Abstract][Full Text] [Related]
11. What Factors Are Associated With Implant Breakage and Revision After Intramedullary Nailing for Femoral Metastases?
Willeumier JJ; Kaynak M; van der Zwaal P; Meylaerts SAG; Mathijssen NMC; Jutte PC; Tsagozis P; Wedin R; van de Sande MAJ; Fiocco M; Dijkstra PDS
Clin Orthop Relat Res; 2018 Sep; 476(9):1823-1833. PubMed ID: 30566108
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of en-bloc resection and late onset of bone metastasis in patients with bone-seeking carcinomas of the kidney, breast, lung, and prostate: SSG study on 672 operated skeletal metastases.
Ratasvuori M; Wedin R; Hansen BH; Keller J; Trovik C; Zaikova O; Bergh P; Kalen A; Laitinen M
J Surg Oncol; 2014 Sep; 110(4):360-5. PubMed ID: 24889389
[TBL] [Abstract][Full Text] [Related]
13. The Clinical and Economic Impacts of Skeletal-Related Events Among Medicare Enrollees With Prostate Cancer Metastatic to Bone.
McDougall JA; Bansal A; Goulart BH; McCune JS; Karnopp A; Fedorenko C; Greenlee S; Valderrama A; Sullivan SD; Ramsey SD
Oncologist; 2016 Mar; 21(3):320-6. PubMed ID: 26865591
[TBL] [Abstract][Full Text] [Related]
14. Prognostic indicators of outcome for patients with skeletal metastases from carcinoma of the prostate.
Shepherd KL; Cool P; Cribb G
Bone Joint J; 2018 Dec; 100-B(12):1647-1654. PubMed ID: 30499326
[TBL] [Abstract][Full Text] [Related]
15. LUMiC
Bus MP; Szafranski A; Sellevold S; Goryn T; Jutte PC; Bramer JA; Fiocco M; Streitbürger A; Kotrych D; van de Sande MA; Dijkstra PD
Clin Orthop Relat Res; 2017 Mar; 475(3):686-695. PubMed ID: 27020434
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of skeletal complications and their impact on survival of hormone refractory prostate cancer patients in Japan.
Inoue T; Segawa T; Kamba T; Yoshimura K; Nakamura E; Nishiyama H; Ito N; Kamoto T; Habuchi T; Ogawa O
Urology; 2009 May; 73(5):1104-9. PubMed ID: 19394511
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of the specific endothelin-A receptor antagonist ZD4054 in patients with hormone-resistant prostate cancer and bone metastases who were pain free or mildly symptomatic: a double-blind, placebo-controlled, randomised, phase 2 trial.
James ND; Caty A; Borre M; Zonnenberg BA; Beuzeboc P; Morris T; Phung D; Dawson NA
Eur Urol; 2009 May; 55(5):1112-23. PubMed ID: 19042080
[TBL] [Abstract][Full Text] [Related]
18. Natural History of Clinical Recurrence Patterns of Lymph Node-Positive Prostate Cancer After Radical Prostatectomy.
Moschini M; Sharma V; Zattoni F; Quevedo JF; Davis BJ; Kwon E; Karnes RJ
Eur Urol; 2016 Jan; 69(1):135-42. PubMed ID: 25865061
[TBL] [Abstract][Full Text] [Related]
19. Importance of non-regional lymph nodes in assigning risk in primary metastatic prostate cancer.
Ali A; Hoyle A; Mistry H; Clarke NW
BJU Int; 2019 Jan; 123(1):65-73. PubMed ID: 29777564
[TBL] [Abstract][Full Text] [Related]
20. Impact of body mass index on clinico-pathological parameters and outcome in patients with metastatic prostate cancer.
Mohammed AA; El-Tanni H; Ghanem HM; Farooq MU; El Saify AM; Al-Zahrani AS; El-Shentenawy A; El-Khatib HM
J Egypt Natl Canc Inst; 2015 Sep; 27(3):155-9. PubMed ID: 26227217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
